Effect of Flibanserin Treatment on Body Weight in Premenopausal and Postmenopausal Women with Hypoactive Sexual Desire Disorder: A Post Hoc Analysis

Background: Flibanserin, a 5-HT(1A) agonist and 5-HT(2A) antagonist, is indicated for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. This post hoc analysis evaluated the effect of flibanserin treatment on body weight in premenopausal and postm...

Descripción completa

Detalles Bibliográficos
Autores principales: Kornstein, Susan G., Simon, James A., Apfel, Stuart C., Yuan, James, Barbour, Krista A., Kissling, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695746/
https://www.ncbi.nlm.nih.gov/pubmed/28817365
http://dx.doi.org/10.1089/jwh.2016.6230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695746/
https://www.ncbi.nlm.nih.gov/pubmed/28817365
http://dx.doi.org/10.1089/jwh.2016.6230

Ejemplares similares